Clinical Trials Browser

Not yet recruiting × INDUSTRY × Mesothelioma, Malignant × Clear all

Mesothelioma, Malignant

NCT05425576 2024-03-15

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Phase 2 Not yet recruiting

63 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05698238 2023-03-15

CAMP1

Phase 1 Not yet recruiting

50 enrolled

BreastGenitourinaryHead & NeckOther solid neoplasmThoracic

Clear-cell metastatic renal cell carcinoma, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

CAMP1